Sarepta Therapeutics, Inc.
(SRPT - NASDAQ)
20,98 USD
📋 Profilo Aziendale

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

|